COVID-19 Public Health Bulletin for French Guiana, November 2021

Key Points

  • COVID-19 Surveillance

    • Multi-source, consisting of systems designed to be comprehensive and/or descriptive

    • Enabling the tracking and description of the epidemic in all its aspects

    • First-time implementation of a system to centralize all diagnostic tests for a disease in real time (available starting in May 2020)

  • Study period for the completion of this BSP

    • From March 2020 to early October 2021

    • Covering the first four waves of the epidemic, with the latest wave nearing completion.

      • Wave 1 – late May to late September 2020 (weeks 21–2020 to 38–2020)

      • Wave 2 – mid-November to mid-February 2021 (weeks 47–2020 to 5–2021)

      • Wave 3 – late March to early August (weeks 12–2021 to 31–2021)

      • Wave 4 – starting in early August (week 32-2021, nearing completion)

  • Epidemic dynamics in French Guiana

    • Influenced by regional characteristics (constant travel to and from mainland France and Latin America, the territory’s size and low population density, disadvantaged populations, insufficient vaccination coverage)

    • Epidemic dynamics reflected in all data sources

    • A first wave that was less intense and shorter than in other regions, but which placed significant strain on the healthcare system

    • A second wave in late 2020, of moderate intensity, with no major health impact

    • A third wave (Gamma in March 2021) and a fourth wave immediately afterward (Delta in August 2021) of high intensity and severe health impact, sweeping across the region from east to west, against a backdrop of insufficient vaccination coverage

  • Key data for French Guiana (November 2021)

    • 451,317 people tested and 44,308 identified as positive

    • 4,649 hospitalizations, including 685 in critical care; 312 deaths in the hospital

    • 480 cases reported by sentinel intensive care units; median age of 61; 90% had one or more comorbidities; median length of stay of 9 days

    • Very few cases reported and no significant mortality reported in long-term care facilities

    • 48% of people aged 65 to 74 had received at least one dose; 43.6% had completed the full vaccination series by November 2021

    • 39.1% of those aged 12 and older had received at least one dose; 33.8% had completed the full vaccination series by November 2021

    • A cumulative total of 17 weeks of lockdown and 32 weeks of curfew since March 2020.

    • In 2021, during the third and fourth waves, 8.4% of those who tested positive were hospitalized, 20% of whom were in intensive care.

    • 9.7% of all people admitted to the hospital died, amounting to 222 deaths during the third and fourth waves.

In relation to

Our latest news

news

Extreme heat affects us all: let’s take the right precautions

news

G7 Summit in Evian: Enhanced Health Monitoring

news

“Protecting the Public from the Risks of Alcohol.” The special report in *La...